These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10412034)
1. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein. Galderisi U; Di Bernardo G; Cipollaro M; Jori FP; Piegari E; Cascino A; Peluso G; Melone MA J Cell Biochem; 1999 Sep; 74(3):313-22. PubMed ID: 10412034 [TBL] [Abstract][Full Text] [Related]
2. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Elliott K; Ge K; Du W; Prendergast GC Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017 [TBL] [Abstract][Full Text] [Related]
3. Bin1 mediates apoptosis by c-Myc in transformed primary cells. DuHadaway JB; Sakamuro D; Ewert DL; Prendergast GC Cancer Res; 2001 Apr; 61(7):3151-6. PubMed ID: 11306501 [TBL] [Abstract][Full Text] [Related]
4. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266 [TBL] [Abstract][Full Text] [Related]
5. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878 [TBL] [Abstract][Full Text] [Related]
6. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Sakamuro D; Elliott KJ; Wechsler-Reya R; Prendergast GC Nat Genet; 1996 Sep; 14(1):69-77. PubMed ID: 8782822 [TBL] [Abstract][Full Text] [Related]
8. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544 [TBL] [Abstract][Full Text] [Related]
9. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821 [TBL] [Abstract][Full Text] [Related]
10. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells. Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166 [TBL] [Abstract][Full Text] [Related]
12. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121 [TBL] [Abstract][Full Text] [Related]
13. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma. Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541 [TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679 [TBL] [Abstract][Full Text] [Related]
15. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. Wechsler-Reya R; Elliott K; Herlyn M; Prendergast GC Cancer Res; 1997 Aug; 57(15):3258-63. PubMed ID: 9242458 [TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha. Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648 [TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Pession A; Tonelli R; Fronza R; Sciamanna E; Corradini R; Sforza S; Tedeschi T; Marchelli R; Montanaro L; Camerin C; Franzoni M; Paolucci G Int J Oncol; 2004 Feb; 24(2):265-72. PubMed ID: 14719101 [TBL] [Abstract][Full Text] [Related]
18. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells. Chen J; Zhe X Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835 [TBL] [Abstract][Full Text] [Related]
20. Regulation of p27 in the process of neuroblastoma N2A differentiation. Muñoz JP; Sánchez JR; Maccioni RB J Cell Biochem; 2003 Jun; 89(3):539-49. PubMed ID: 12761887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]